Articles published by ZyVersa Therapeutics
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
ZyVersa Therapeutics Reports Second Quarter, 2024 Financial Results and Provides Business Update
August 09, 2024
From ZyVersa Therapeutics
Via GlobeNewswire
Tickers
ZVSA
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update
May 15, 2024
From ZyVersa Therapeutics
Via GlobeNewswire
Tickers
ZVSA
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
ZyVersa Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
March 25, 2024
From ZyVersa Therapeutics
Via GlobeNewswire
Tickers
ZVSA
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
ZyVersa Therapeutics Announces Equity Research Coverage Initiated by Noble Capital Markets
January 04, 2024
From ZyVersa Therapeutics
Via GlobeNewswire
Tickers
ZVSA
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
ZyVersa Therapeutics CEO, Stephen C. Glover, Issues Letter to Shareholders Providing Outlook for 2024
January 03, 2024
From ZyVersa Therapeutics
Via GlobeNewswire
Tickers
ZVSA
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
ZyVersa Therapeutics’ CEO, Stephen C. Glover, to Participate in BIO Partnering @ JPM During “J.P. Morgan Week 2024”
December 18, 2023
From ZyVersa Therapeutics
Via GlobeNewswire
Tickers
ZVSA
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
![](https://ml.globenewswire.com/media/9ca5d520-abbc-4128-a65d-fc012acd814d/small/zyversarev-cmyk-jpg.jpg)
ZyVersa Therapeutics, Inc. Announces Reverse Stock Split and Increase in Authorized Shares of Common Stock
November 30, 2023
From ZyVersa Therapeutics
Via GlobeNewswire
Tickers
ZVSA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.